Related references
Note: Only part of the references are listed.Targeting tumor cells with pyrazolo[3,4-d] pyrimidine scaffold: A literature review on synthetic approaches, structure activity relationship, structural and target-based mechanisms
Mohamed A. Abdelgawad et al.
ARABIAN JOURNAL OF CHEMISTRY (2022)
Design and Synthesis of New CDK2 Inhibitors Containing Thiazolone and Thiazolthione Scafold with Apoptotic Activity
Nour E. A. Abd El-Sattar et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2021)
Synthesis of a new series of pyrazolo [1,5-a]pyrimidines as CDK2 inhibitors and anti-leukemia
Samar J. Almehmadi et al.
BIOORGANIC CHEMISTRY (2021)
Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study
Mamaru Bitew et al.
PLOS ONE (2021)
Molecular mechanism concerning conformational changes of CDK2 mediated by binding of inhibitors using molecular dynamics simulations and principal component analysis
S. S. Liang et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2021)
Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations
Jianzhong Chen et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Synthesis, cytotoxicity of some pyrazoles and pyrazolo[1,5-α]pyrimidines bearing benzothiazole moiety and investigation of their mechanism of action
Ebtehal M. Husseiny
BIOORGANIC CHEMISTRY (2020)
Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase
Ahmed Ismail et al.
STEROIDS (2020)
Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold
Daniel J. Baillache et al.
RSC MEDICINAL CHEMISTRY (2020)
Synthesis, biological evaluation and DFT calculation of novel pyrazole and pyrimidine derivatives
Ahmad M. Farag et al.
JOURNAL OF MOLECULAR STRUCTURE (2019)
Synthesis, molecular structure and multiple biological activities of N-(3-methoxyphenyl)-3-(pyridin-4-yl)-1H-pyrazole-5-carboxamide
Rajendran Nithyabalaji et al.
JOURNAL OF MOLECULAR STRUCTURE (2019)
Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a] pyrimidine scaffold with apoptotic activity
Ghada M. E. Ali et al.
BIOORGANIC CHEMISTRY (2019)
Synthesis of 4,6-disubstituted pyrazolo[3,4-d ]pyrimidine analogues: Cyclin-dependent kinase 2 (CDK2) inhibition, molecular docking and anticancer evaluation
Srinivasulu Cherukupalli et al.
JOURNAL OF MOLECULAR STRUCTURE (2019)
Synthesis, anticancer evaluation, and molecular docking studies of some novel 4,6-disubstituted pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 (CDK2) inhibitors
Srinivasulu Cherukupalli et al.
BIOORGANIC CHEMISTRY (2018)
Design, synthesis and 3D QSAR based pharmacophore study of novel imatinib analogs as antitumor-apoptotic agents
Iten M. Fawzy et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Design, Synthesis and Antitumor Evaluation of Novel Pyrazolopyrimidines and Pyrazoloquinazolines
Mohamed El-Naggar et al.
MOLECULES (2018)
ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database
Jie Dong et al.
JOURNAL OF CHEMINFORMATICS (2018)
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a] pyrimidine scaffold
Srinivasulu Cherukupalli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, synthesis and anticancer evaluation of novel pyrazole, pyrazolo[3,4-d]pyrimidine and their glycoside derivatives
Ibrahim F. Nassar et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2017)
BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity
Wei Zou et al.
ONCOLOGY LETTERS (2016)
Bioluminescent kinase strips: A novel approach to targeted and flexible kinase inhibitor profiling
J. Hennek et al.
ANALYTICAL BIOCHEMISTRY (2016)
Synthesis and molecular docking of N′-arylidene-5-(4-chlorophenyl)-1-(3,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbohydrazides as novel hypoglycemic and antioxidant dual agents
Eduardo Hernandez-Vazquez et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Design, synthesis and antitumor activity of novel pyrazolo[3,4-d]pyrimidine derivatives as EGFR-TK inhibitors
Mohamed A. Abdelgawad et al.
BIOORGANIC CHEMISTRY (2016)
Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents
Ameur Rahmouni et al.
BIOORGANIC CHEMISTRY (2016)
Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents
Nasser S. M. Ismail et al.
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2
Yan Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
A convenient synthesis and molecular modeling study of novel pyrazolo[3,4-d]pyrimidine and pyrazole derivatives as anti-tumor agents
Ibrahim F. Nassar et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Targeting epigenetic regulators for cancer therapy
Susan Wee et al.
ANNALS REPORTS (2014)
Biologically Driven Synthesis of Pyrazolo[3,4-d]pyrimidines As Protein Kinase Inhibitors: An Old Scaffold As a New Tool for Medicinal Chemistry and Chemical Biology Studies
Silvia Schenone et al.
CHEMICAL REVIEWS (2014)
Medicinal attributes of pyrazolo[3,4-d]pyrimidines: A review
Monika Chauhan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors
Yan Li et al.
MOLECULAR BIOSYSTEMS (2013)
Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo [3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1
Jean-Yves Le Brazidec et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Synthesis and QSAR study of novel cytotoxic spiro[3H-indole-3,2′(1′H)-pyrrolo[3,4-c]pyrrole]-2,3′,5′(1H,2′aH,4′H)-triones
Adel S. Girgis et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells
Guido Bocci et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Synthesis and in vitro cytotoxic activity of novel pyrazolo[3,4-d]pyrimidines and related pyrazole hydrazones toward breast adenocarcinoma MCF-7 cell line
Ghaneya Sayed Hassan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Synthesis and anticancer effects of some novel pyrazolo[3,4-d]pyrimidine derivatives by generating reactive oxygen species in human breast adenocarcinoma cells
Aymn E. Rashad et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Design, Synthesis, Biological Activity, and ADME Properties of Pyrazolo[3,4-d]pyrimidines Active in Hypoxic Human Leukemia Cells: A Lead Optimization Study
Marco Radi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A convenient synthesis and molecular modeling study of novel purine and pyrimidine derivatives as CDK2/cyclin A3 inhibitors
Abdel-Sattar S. Hamad Elgazwy et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Pyrazolopyrimidines as highly potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): Optimization of the 1-substituent
Kevin J. Curran et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and antiviral evaluation of novel 5-(N-Arylaminomethyl-1,3,4-oxadiazol-2-yl)hydrazines and their sugars, 1,2,4-triazoles, tetrazolles and pyrazolyl derivatives
Mohammed T. Abdel-Aal et al.
ARCHIV DER PHARMAZIE (2008)
A new therapeutic approach in Alzheimer disease:: Some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics
Nesrin Goekhan-Kelekci et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design
G Kontopidis et al.
CHEMISTRY & BIOLOGY (2006)
Protein kinases - the major drug targets of the twenty-first century?
P Cohen
NATURE REVIEWS DRUG DISCOVERY (2002)
Share Paper
